Progyny, Inc.
NASDAQ:PGNYMedical - Healthcare Information Services
-$0.05 today
- Market cap
- $2.66B
- Beta
- 1.04
- P/E (TTM)
- 31.4
- EPS (TTM)
- $0.84
Volume 0.88M
Average 1.49M
PGNY Total Assets
Everything the company owns or controls; equal to total liabilities plus equity.
Progyny, Inc.NASDAQ: PGNY
Total Assets · Q2 FY2026 · quarter ended Jun 2026
Total assets falls 5.9% from a year ago
Total assets stood at $715.84M at the end of Q2 FY2026, down 5.9% from a year earlier and up 2.5% from the prior quarter. Over 3 fiscal years it compounded at +11.0% a year.
Context
- Total assets increased in 2 of the last 3 fiscal years.
What to watch
Whether total assets keeps falling in the next quarterly balance sheet after a -5.9% change from a year earlier.
Sources:Balance SheetText generated from reported figures; not investment advice.
Total Assets history
USD · from the balance sheet
- Latest · FY2025
- 742.44M USD
- Year-over-year change
- +22.3%
- 4-year CAGR
- +20.0%
| Period | Period end | Total Assets | YoY change |
|---|---|---|---|
| FY2025 | 2025-12-31 | 742.44M | +22.3% |
| FY2024 | 2024-12-31 | 607.1M | -19.8% |
| FY2023 | 2023-12-31 | 756.62M | +39.3% |
| FY2022 | 2022-12-31 | 542.99M | +51.6% |
| FY2021 | 2021-12-31 | 358.07M | — |
Total Assets vs competitors
How PGNY compares with its peers on the latest reported figures
- PGNY's Jun 2026 total assets of $715.84M is the 2nd highest of the 3 companies compared; the peer median is $1.79B.
- Its year-over-year change of -5.9% is the lowest of 3, against a peer median of +55.1%.
- Over three fiscal years its annual growth of +11.0% compares with a peer median of +7.4%.
| Company | Period | Latest balance | YoY | 3-year CAGR |
|---|---|---|---|---|
| Jul 2026 | $3.27B | -4.3% | +3.6% | |
| Jun 2026 | $715.84M | -5.9% | +11.0% | |
| Mar 2026 | $302.8M | +114.5% | +11.3% | |
| Peer median (excluding PGNY) | $1.79B | +55.1% | +7.4% | |
Competitors are the stored peer set for PGNY. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.
Balance Sheet
Metric | FY2021 Dec 2021 | FY2022 Dec 2022 | FY2023 Dec 2023 | FY2024 Dec 2024 | FY2025 Dec 2025 |
|---|---|---|---|---|---|
| Cash & Equivalents | 91.41M | 120.08M | 97.3M | 162.31M | 112.24M |
| Short-term Investments | 28.01M | 69.22M | 273.79M | 65.64M | 197.86M |
| Net Receivables | 134.56M | 240.07M | 241.87M | 235.32M | 220.29M |
| Inventory | 0 | 0 | 0 | 0 | 0 |
| Other Current Assets | 0 | 4.49M | 27.45M | 9.44M | 21.39M |
| Total Current Assets | 258.54M | 433.86M | 640.41M | 472.72M | 551.78M |
| Property, Plant & Equipment (Net) | 12.83M | 15.27M | 27.82M | 29.63M | 54.92M |
| Goodwill | 11.88M | 11.88M | 11.88M | 15.53M | 19.98M |
| Intangible Assets | 599K | 99K | 0 | 1.3M | 6.22M |
| Long-term Investments | 0 | 0 | 0 | 0 | 0 |
| Tax Assets | 71.27M | 77.89M | 73.12M | 84.93M | 93.01M |
| Other Non-current Assets | 2.94M | 3.99M | 3.4M | 2.98M | 16.54M |
| Total Non-current Assets | 99.53M | 109.13M | 116.21M | 134.38M | 190.66M |
| Total Assets | 358.07M | 542.99M | 756.62M | 607.1M | 742.44M |
| Account Payables | 61.4M | 109.29M | 125.43M | 95.1M | 124.07M |
| Short-term Debt | 0 | 0 | 0 | 0 | 0 |
| Tax Payables | 0 | 0 | 0 | 0 | 0 |
| Deferred Revenue | 0 | 0 | 0 | 0 | 0 |
| Other Current Liabilities | 12.26M | 8.88M | 13.05M | 19.87M | 23.48M |
| Total Current Liabilities | 98.82M | 159.54M | 185.95M | 168.63M | 202.39M |
| Long-term Debt | 0 | 0 | 0 | 0 | 0 |
| Deferred Tax Liabilities | 0 | 0 | 0 | 0 | 0 |
| Deferred Revenue (Non-current) | 0 | 0 | 0 | 0 | 0 |
| Other Non-current Liabilities | 0 | 0 | 0 | 0 | 0 |
| Total Non-current Liabilities | 7.42M | 6.48M | 17.24M | 16.41M | 24M |
| Total Liabilities | 106.24M | 166.02M | 203.19M | 185.04M | 226.39M |
| Common Stock | 9K | 9K | 9K | 9K | 9K |
| Retained Earnings | (2.42M) | 27.93M | 89.97M | 144.31M | 202.83M |
| Accumulated OCI | (93K) | 501K | 2.82M | 39K | 498K |
| Other Stockholders Equity | 0 | 0 | 0 | 0 | 0 |
| Minority Interest | 0 | 0 | 0 | 0 | 0 |
| Total Equity | 251.82M | 376.97M | 553.43M | 422.06M | 516.04M |
| Total Debt | 8.65M | 7.71M | 19.39M | 19.27M | 27.73M |
| Net Debt | (82.76M) | (112.37M) | (77.91M) | (143.04M) | (84.51M) |
Progyny, Inc.
NASDAQ:PGNY
Intrinsic Alpha fair value
Locked
Current Price
$36.16
Unlock the intrinsic value to see where the current price sits on the valuation runway.
Valuation runway
LockedGet the intrinsic value and margin of safety with a free account.
Continue the stock analysis
Jump to another research area for this company.